These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure. Motiwala SR; Gaggin HK Curr Heart Fail Rep; 2016 Oct; 13(5):207-218. PubMed ID: 27726056 [TBL] [Abstract][Full Text] [Related]
17. Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action. Bayes-Genis A; Voors AA; Zannad F; Januzzi JL; Mark Richards A; Díez J Eur Heart J; 2018 Aug; 39(30):2793-2799. PubMed ID: 28204449 [No Abstract] [Full Text] [Related]
18. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439 [TBL] [Abstract][Full Text] [Related]
19. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure. Weber KT; Brilla CG; Campbell SE; Zhou G; Matsubara L; Guarda E Blood Press; 1992 Aug; 1(2):75-85. PubMed ID: 1366263 [TBL] [Abstract][Full Text] [Related]
20. Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use. D'Elia E; Vaduganathan M; Gori M; Gavazzi A; Butler J; Senni M Eur J Heart Fail; 2015 Dec; 17(12):1231-9. PubMed ID: 26493383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]